134 related articles for article (PubMed ID: 25102583)
1. [Management of extensive disease small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party].
Grigoriu B; Meert AP;
Rev Med Brux; 2014; 35(3):164-8. PubMed ID: 25102583
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of small cell lung cancer: limited disease. Guidelines of clinical practice made by the European Lung Cancer Working Party].
Holbrechts S; Roelandts M;
Rev Med Brux; 2014; 35(3):160-3. PubMed ID: 25102582
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of small cell lung cancer: extensive diseases. Guidelines of clinical practice made by the European Lung Cancer Working Party].
European Lung Cancer Working Party
Rev Med Brux; 2008; 29(5):455-70. PubMed ID: 19055119
[TBL] [Abstract][Full Text] [Related]
4. [Management of unresectable non-metastatic non-small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party].
Paesmans M;
Rev Med Brux; 2014; 35(3):140-4. PubMed ID: 25102580
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of non-small cell lung cancer: Advanced (metastatic) disease (corrected)].
Berghmans T;
Rev Med Brux; 2014; 35(3):145-59. PubMed ID: 25102581
[TBL] [Abstract][Full Text] [Related]
6. [Management of resectable non-small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party].
Sculier JP;
Rev Med Brux; 2014; 35(3):134-9. PubMed ID: 25102579
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of small cell lung cancer: limited diseases. Guidelines of clinical practice made by the European Lung Cancer Working Party].
European Lung Cancer Working Party
Rev Med Brux; 2008; 29(3):159-67. PubMed ID: 18705597
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of non-small cell lung cancer: advanced (metastatic) disease. Guidelines of clinical practice made by the European Lung Cancer Working Party].
European Lung Cancer Working Party
Rev Med Brux; 2007; 28(6):495-511. PubMed ID: 18265809
[TBL] [Abstract][Full Text] [Related]
9. Emerging drugs for small-cell lung cancer.
Metro G; Cappuzzo F
Expert Opin Emerg Drugs; 2009 Dec; 14(4):591-606. PubMed ID: 19694501
[TBL] [Abstract][Full Text] [Related]
10. [Management of unresectable non-metastatic non-small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party].
European Lung Cancer Working Party
Rev Med Brux; 2006; 27(3):152-61. PubMed ID: 16894953
[TBL] [Abstract][Full Text] [Related]
11. Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published controlled trials.
Bozcuk H; Artac M; Ozdogan M; Savas B
Cancer; 2005 Dec; 104(12):2650-7. PubMed ID: 16284984
[TBL] [Abstract][Full Text] [Related]
12. Thalidomide in small cell lung cancer: wrong drug or wrong disease?
Rüegg C; Peters S
J Natl Cancer Inst; 2009 Aug; 101(15):1034-5. PubMed ID: 19608998
[No Abstract] [Full Text] [Related]
13. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
[TBL] [Abstract][Full Text] [Related]
14. Negative data from lung cancer trial may change practice guidelines, study designs.
McNeil C
J Natl Cancer Inst; 2006 Nov; 98(21):1518-20. PubMed ID: 17077353
[No Abstract] [Full Text] [Related]
15. [Chemotherapy for lung cancer].
Fujiwara K; Eguchi K
Nihon Rinsho; 2000 May; 58(5):1087-92. PubMed ID: 10824554
[TBL] [Abstract][Full Text] [Related]
16. The future of adjuvant chemotherapy for resected non-small cell lung cancer.
Vansteenkiste JF; Schildermans RH
Expert Rev Anticancer Ther; 2005 Feb; 5(1):165-75. PubMed ID: 15757448
[TBL] [Abstract][Full Text] [Related]
17. [Management of resectable non-small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party].
European Lung Cancer Working Party
Rev Med Brux; 2006; 27(1):29-38. PubMed ID: 16608009
[TBL] [Abstract][Full Text] [Related]
18. Mediastinal radiotherapy after multidrug chemotherapy and prophylactic cranial irradiation in patients with SCLC--treatment results after long-term follow-up and literature overview.
Herrmann MK; Bloch E; Overbeck T; Koerber W; Wolff HA; Hille A; Vorwerk H; Hess CF; Muller M; Christiansen H; Pradier O
Cancer Radiother; 2011 Apr; 15(2):81-8. PubMed ID: 20708424
[TBL] [Abstract][Full Text] [Related]
19. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK;
J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033
[TBL] [Abstract][Full Text] [Related]
20. [Evidence-based practice guideline for unresectable advanced lung cancer in 2003].
Fukuoka M; Kurata T; Yamamoto N
Nihon Geka Gakkai Zasshi; 2004 Jul; 105(7):412-6. PubMed ID: 15303441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
